Retina/Vitreous

Top Story

VIDEO: Ozurdex reduces ischemia in diabetic retinopathy in pilot study

May 24, 2017

BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Giuseppe Querques, MD, PhD, discusses a pilot study of Ozurdex (Allergan) in the reduction of ischemia in patients with diabetic retinopathy. Querques reports a three-fold reduction in eyes treated with intravitreal steroids in the eyes studied.

Unique retinal scar identified in Ebola survivors

May 23, 2017
Unique retinal lesions have been observed in some survivors of Ebola virus infection, according to a study. In a case-control prospective study, University of Liverpool…
FDA News

FDA approves Actemra for giant cell arteritis

May 22, 2017
The FDA has approved Actemra for the treatment of adults with giant cell arteritis. “Rheumatologists will finally have available an option for their patients…
Meeting News

OCTA used to assess macular vessel density in Stargardt disease

May 17, 2017
BALTIMORE — Patients with Stargardt disease had a lower vessel density in the deep retina, according to a study presented at the Association for Research in Vision…
Clinical Science Imaging

Optic Disc and Retinal Nerve Fiber Layer Parameters of Eyes With Keratoconus

Ophthalmic Surgery, Lasers and Imaging Retina, September 2012, Volume 43 Issue 5
To evaluate optic nerve head (ONH) characteristics and retinal nerve fiber layer (RNFL) thickness measurements in…
More »
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Featured
Video
Meeting News

VIDEO: Eyes with optic nerve obscuration in retinoblastoma may be saved

May 8, 2017
More »
Meeting NewsVideo

VIDEO: Ozurdex reduces ischemia in diabetic retinopathy in pilot study

May 24, 2017
BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Giuseppe Querques, MD, PhD, discusses a pilot study of Ozurdex…

Unique retinal scar identified in Ebola survivors

May 23, 2017
Unique retinal lesions have been observed in some survivors of Ebola virus infection, according to a study. In a case-control prospective study…

FDA News

FDA approves Actemra for giant cell arteritis

May 22, 2017
The FDA has approved Actemra for the treatment of adults with giant cell arteritis. “Rheumatologists will finally have available an option for…

Meeting News

OCTA used to assess macular vessel density in Stargardt disease

May 17, 2017
BALTIMORE — Patients with Stargardt disease had a lower vessel density in the deep retina, according to a study presented at the Association…

Meeting NewsVideo

VIDEO: Review shows anti-VEGFs improve visual, anatomic results in retinal vein occlusion cases

May 15, 2017
BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Nikolas J.S. London, MD, discusses a large, cross-sectional…

Meeting NewsVideo

VIDEO: Sirolimus reduces vitreous haze in patients with posterior uveitis

May 14, 2017
BALTIMORE – Phase 3 studies of intravitreal sirolimus demonstrated reduced vitreous haze in patients with noninfectious posterior uveitis…

Video

VIDEO: Speaker raises question of earlier alternative strategies for patients with persistent edema

May 13, 2017
BALTIMORE – A retrospective analysis of DRCR.net Protocol I data showed patients with persistent edema treated with ranibizumab demonstrated…

Blog

BLOG: How we will get to office-based surgery

May 12, 2017
When a patient asks, “When can we do my surgery, doctor?” wouldn’t it be great if you could answer, “Have you got 15 minutes…

Point/Counter

Is a day 1 postop review necessary after pars plana vitrectomy?

Ocular Surgery News U.S. Edition, May 25, 2017
Point In my opinion, the answer is a resounding, absolute yes. The first and most important data point necessary to reduce risk in any intraocular…

Lindstrom's Perspective

Ophthalmology continues to move toward ASC and office-based surgery

Ocular Surgery News U.S. Edition, May 25, 2017
Richard L. Lindstrom, MD
In my now 40 years of ophthalmology practice, I have always had access to a hospital-based operating suite, an ASC-based operating suite and an…

More Headlines »
Advertisement
Advertisement